A detailed history of Steward Financial Group LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Steward Financial Group LLC holds 17 shares of IRWD stock, worth $77. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Holding current value
$77
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$8.25 - $11.35 $140 - $192
17 New
17 $0
Q1 2023

May 05, 2023

BUY
$10.37 - $12.56 $829 - $1,004
80 Added 275.86%
109 $1,000
Q4 2022

Feb 13, 2023

BUY
$9.9 - $12.43 $287 - $360
29 New
29 $0
Q2 2022

Jul 22, 2022

BUY
$11.05 - $12.72 $718 - $826
65 New
65 $0

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $702M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.